Latest Commercialization News

Aeris Resources has secured a $60 million Guarantee Facility with Washington H. Soul Pattinson, replacing its ANZ environmental bonding, and extended its $50 million Term Facility to August 2026 under favourable terms.

Cardiex Limited has successfully raised $2.4 million through an institutional placement to boost manufacturing and commercial activities for its CONNEQT Pulse device.

Empire Energy Group has launched a $28 million equity raise to finance critical development activities in the Beetaloo Basin, targeting first gas sales from its Carpentaria Pilot Project in 2025. The capital raise, combined with a $65 million financing package, underpins the company’s ambition to commercialize one of Australia’s largest low-CO2 shale gas resources.

OncoSil Medical has launched a Security Purchase Plan offering discounted shares and free options to eligible shareholders, aiming to accelerate commercialization of its pancreatic cancer treatment device.

ClearVue Technologies’ subsidiary OptiCrop has secured its inaugural commercial project, an $80,000 greenhouse installation leveraging proprietary ground-source heat exchange technology. This milestone underscores ClearVue’s strategic expansion into sustainable protected cropping and greenhouse agriculture.

Emmerson Resources has resumed drilling at its White Devil gold deposit, aiming to expand and refine its substantial mineral resource ahead of key development studies.

Pursuit Minerals has dispatched high-purity lithium carbonate samples from its Argentine pilot plant to potential partners, advancing feasibility studies for a 5,000tpa operation while exploring strategic acquisitions in precious and base metals.

Cann Group Limited has resolved its legal dispute with Rua Biosciences, paving the way for new commercial agreements to supply medicinal cannabis products across Australia and New Zealand.

Adveritas Limited reports a record 61% increase in annualised recurring revenue, driven by strong gains in sports betting and new product launches, while preparing for a strategic expansion into North America.

Manuka Resources is poised to restart silver production at its Wonawinta Mine targeting 13.2 million ounces, while progressing its large-scale vanadium-titanium-magnetite project in New Zealand with a robust $1.26 billion valuation.

Recce Pharmaceuticals has completed a A$15.8 million capital raise to fund pivotal Phase 3 clinical trials and progress its FDA application, positioning the company for potential commercial breakthroughs in antibiotic-resistant infections.

Freehill Mining has produced a high-grade magnetite concentrate of approximately 66% iron from its Yerbas Buenas mine bulk sample, setting the stage for renewed mining operations in Chile.